Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Whole body vibration ther… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Whole body vibration therapy in patients with Duchenne muscular dystrophy - A prospective observational study.

Artikel i vetenskaplig tidskrift
Författare Ann-Charlott Söderpalm
Anna-Karin Kroksmark
P Magnusson
Jon Karlsson
Mar Tulinius
Diana Swolin-Eide
Publicerad i Journal of musculoskeletal & neuronal interactions
Volym 13
Nummer/häfte 1
Sidor 13-8
ISSN 1108-7161
Publiceringsår 2013
Publicerad vid Institutionen för kliniska vetenskaper, Avdelningen för pediatrik
Institutionen för kliniska vetenskaper, Avdelningen för ortopedi
Sidor 13-8
Språk en
Länkar www.ncbi.nlm.nih.gov/pubmed/2344591...
Ämnesord Vibration Therapy, DXA, DXL, pQCT, Bone Mineral Density, Sclerostin
Ämneskategorier Ortopedi, Pediatrik

Sammanfattning

Objectives: To study the tolerability of whole body vibration (WBV) exercise in patients with Duchenne muscular dystrophy (DMD) and its effects on muscle and bone. Methods: WBV was performed two to three times a week for three months. Motor function, muscle strength, bone mass and biochemical markers of bone and mineral metabolism were analyzed before and after the WBV period at 0, 3, 6 and 12 months. Results: Six ambulatory patients with DMD aged 5.7-12.5 years completed the study. No changes in creatine kinase activity were found, indicating that the WBV exercise did not further damage the skeletal muscle. No significant changes in bone mass, muscle strength or bone markers were found. However, there was a non-significant trend for the bone formation marker, bone-specific alkaline phosphate, to increase from a mean of 59 U/L to 73 U/L after three months of WBV. The bone formation marker levels returned to baseline three months after discontinuing WBV and were still at that level after nine months. Conclusions: WBV therapy appears to be safe and well tolerated among ambulatory DMD patients. The potential benefits of WBV on bone and muscle in DMD remain to be elucidated.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?